Peptic Ulcers Pipeline Review2019 [Published by First View Insight] Prices from USD $1063

23:40 EST 3 Feb 2020 | BioPortfolio Reports

Firstview Insight's Peptic Ulcers Pipeline Review2019 provides an overview of the pipeline landscape of Peptic Ulcers It provides comprehensive insights of all the clinical and nonclinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the upcoming and existing competitors in their separate therapeutic spaces. The report provides detailed description of the competitor profiles with key milestones and evidence along with analysis by mechanism of action; route of administration; molecule type; stage of development. Information obtained from multiple sources will be used to triangulate and update the profiles. The report also provides key events in the last year related to the indication. This report provides detailed analysis of all the products along with the companies involved.

Peptic ulcer diseasePUD is a break in the inner lining of thestomach, the first part of thesmall intestine, or sometimes the loweresophagus.An ulcer in the stomach is called agastric ulcer, while one in the first part of the intestines is aduodenal ulcer.Complications may include bleeding, perforation, and blockage of the stomach.Common causes include the bacteria Helicobacter pylori and nonsteroidal antiinflammatory drugs NSAIDs. Other, less common causes include tobacco smoking, stress due to serious illness, Behcet disease, ZollingerEllison syndrome, Crohn disease, and liver cirrhosis.Signs and symptoms of a peptic ulcer can include one or more of the following:

abdominal pain, classically epigastric, strongly correlated with mealtimes. In case of duodenal ulcers, the pain appears about three hours after taking a meal and wakes the person from sleep;

bloating and abdominal fullness


nausea and copious vomiting

loss of appetite and weight loss, in gastric ulcer

weight gain, in duodenal ulcer, as the pain is relieved by eating;



rarely, an ulcer can lead to a gastric or duodenal perforation, which leads to acute peritonitis and extreme, stabbing pain, and requires immediate surgery.

Drug Profile Overview:

The pipeline section provides descriptive drug profiles for the pipeline products including product description, mechanism of action, route of administration, molecule type, technology involved, chemical information.

Clinical Trial Overview:

This section of the report focuses on the clinical activity of the molecule. It includes both clinical and preclinical activity which provides detailed information about the safety, efficacy, tolerability, toxicity of pipeline drugs. A graphical representation of the clinical trial landscape of pipeline therapy which includes information about phase of development, trial design, treatment arms, dosage and frequency, formulation of the drug, primary and secondary completion date, enrolment number, exclusion and inclusion criteria, line of therapy. This section also includes the clinical trial results and analysis based on those results.

Product Development Activity:

This section of the report focuses on detail information about designations, exclusivity details, technology, licensing and collaboration, funding and financing, key milestones and various other development activities.

Company Overview:

Company profile includes the detail about type of company, headquarter, global presence, research focus and key financial


The report provides a competitive landscape

The report also provides clinical trial landscape of the pipeline drugs including status; trial phase; sponsor type and endpoint status

The report provides the list of companies which are the most active in the pipeline

The report covers pipeline products based on various stages of development ranging from preregistration till discovery

The report provides descriptive drug profiles which includes product description; comprising detailed mechanism of action MoA; route of administration RoA; Stage of development; clinical trial status; licensing and collaboration details other developmental activities

The report features comparative analysis of product profiles based on molecule type; mechanism of action MoA; route of administration RoA

The report summarizes all the dormant and discontinued pipeline projects

The report also provides latest news for the past one year

Reasons To Buy

To identifying prominent players in the treatment landscape

To determine the drivers; barriers and unmet need in the treatment space

Gain strategically significant competitor information; analysis; and insights to formulate effective RD strategies

Define inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

To understand the composition of the pipeline in terms of molecule type; molecular target; mechanism of action and route of administration

List of products

omeprazole Prilosec

lansoprazole Prevacid

rabeprazole Aciphex

esomeprazole Nexium

pantoprazole Protonix.

Original Article: Peptic Ulcers Pipeline Review2019 [Published by First View Insight] Prices from USD $1063


More From BioPortfolio on "Peptic Ulcers Pipeline Review2019 [Published by First View Insight] Prices from USD $1063"

Quick Search

Relevant Topic

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...